GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction
Publication
, Conference
Marzano, F; Liccardo, D; Koch, WJ; Rengo, G; Cannavo, A
Published in: Vascular Pharmacology
September 2020
Duke Scholars
Published In
Vascular Pharmacology
DOI
ISSN
1537-1891
Publication Date
September 2020
Volume
132
Start / End Page
106737 / 106737
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Marzano, F., Liccardo, D., Koch, W. J., Rengo, G., & Cannavo, A. (2020). GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction. In Vascular Pharmacology (Vol. 132, pp. 106737–106737). Elsevier BV. https://doi.org/10.1016/j.vph.2020.106737
Marzano, Federica, Daniela Liccardo, Walter J. Koch, Giuseppe Rengo, and Alessandro Cannavo. “GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction.” In Vascular Pharmacology, 132:106737–106737. Elsevier BV, 2020. https://doi.org/10.1016/j.vph.2020.106737.
Marzano F, Liccardo D, Koch WJ, Rengo G, Cannavo A. GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction. In: Vascular Pharmacology. Elsevier BV; 2020. p. 106737–106737.
Marzano, Federica, et al. “GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction.” Vascular Pharmacology, vol. 132, Elsevier BV, 2020, pp. 106737–106737. Crossref, doi:10.1016/j.vph.2020.106737.
Marzano F, Liccardo D, Koch WJ, Rengo G, Cannavo A. GRK2 downstream aldosterone and mineralocorticoid receptor system induces cardiac insulin-resistance and β-adrenergic dysfunction. Vascular Pharmacology. Elsevier BV; 2020. p. 106737–106737.
Published In
Vascular Pharmacology
DOI
ISSN
1537-1891
Publication Date
September 2020
Volume
132
Start / End Page
106737 / 106737
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences